Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hochhauser

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|July 11, 1998
Molecular biologists map pathways to gastrointestinal cancerD Hochhauser
Anti-Cancer Drugs|January 22, 1998
Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancerD Hochhauser
Lancet (London, England)|August 30, 2000
Relevance of mitochondrial DNA in cancerD Hochhauser
Lancet (London, England)|May 5, 1999
Cancer researchers get down to arrays at AACR. American Association for Cancer ResearchD Hochhauser
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Of mice and men: patient-derived xenografts in cancer medicineD Hochhauser, C Caldas
Lancet (London, England)|September 21, 2002
Realising the potential of targeted therapies in oncologyC Craddock, D Hochhauser
British Medical Bulletin|January 1, 1991
Drug resistanceD Hochhauser, A L Harris
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Mechanisms of multidrug resistance in cancer treatmentA L Harris, D Hochhauser
Cancer Treatment Reviews|April 1, 1993
The role of topoisomerase II alpha and beta in drug resistanceD Hochhauser, A L Harris
Molecular Pharmacology|March 22, 2001
Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugsB Tolner, J A Hartley, D Hochhauser
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|July 11, 1998
Molecular biologists map pathways to gastrointestinal cancerD Hochhauser
Anti-Cancer Drugs|January 22, 1998
Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancerD Hochhauser
Lancet (London, England)|August 30, 2000
Relevance of mitochondrial DNA in cancerD Hochhauser
Lancet (London, England)|May 5, 1999
Cancer researchers get down to arrays at AACR. American Association for Cancer ResearchD Hochhauser
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Of mice and men: patient-derived xenografts in cancer medicineD Hochhauser, C Caldas
Lancet (London, England)|September 21, 2002
Realising the potential of targeted therapies in oncologyC Craddock, D Hochhauser
British Medical Bulletin|January 1, 1991
Drug resistanceD Hochhauser, A L Harris
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Mechanisms of multidrug resistance in cancer treatmentA L Harris, D Hochhauser
Cancer Treatment Reviews|April 1, 1993
The role of topoisomerase II alpha and beta in drug resistanceD Hochhauser, A L Harris
Molecular Pharmacology|March 22, 2001
Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugsB Tolner, J A Hartley, D Hochhauser
Pageof 5